To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
Daily synthesis runs at 06:00 UTC. This bill's consensus draft will appear on the next pass.